Mar 3, 2023 | Announcements, Columbus Business First, Direct-to-Employer Contracting, Kurt Harden, MedBen News, News
MedBen has once again topped the list of Largest Central Ohio Employee Benefits Companies as ranked by Columbus Business First. “We’re celebrating our 85th anniversary this year, and the main reason for this longevity is our people,” said MedBen President and CEO Kurt...
Mar 2, 2023 | Asthma, Cancer, Cholesterol, Cost Savings, Diabetes, Heart, MedBen WellLiving, News, Preventive Care, Primary Care, Reporting, Savings
A new report finds that the primary care workforce has decreased in recent years, and advises that the U.S. should invest more in adding new physicians. It’s a sensible suggestion, considering that primary care has demonstrably contributed to making Americans...
Feb 17, 2023 | Affordable Care Act, Birth Control, Compliance, News, Prescription
On February 2, 2023, the Departments of Labor, Health and Human Services, and Treasury (the “Tri-Agencies”) proposed a rule to expand women’s access to birth control under the Affordable Care Act (ACA). The proposed rule revises the exemption allowances...
Feb 15, 2023 | Compliance, Independent Dispute Resolution (IDR), Lawsuits, News, No Surprises Act (NSA), Regulatory
Independent Dispute Resolution (IDR) review decisions have been placed on hold due to a lawsuit brought forth by the Texas Medical Association (TMA). The lawsuit challenges the Final Rules of the No Surprises Act, specifically those relating to how the Qualified...
Jan 9, 2023 | Announcements, Compliance, News, No Surprises Act (NSA), Regulatory, Uncategorized
Higher fees and an extended reporting deadline are among the updated No Surprises Act (NSA) guidance and relief released by the Departments of Labor, Health and Human Services, and Treasury (the “Tri-Agencies”) on December 23. Specific updates include: An...
Jan 6, 2023 | Drug costs, Drugmakers, News, Prescription, Rx Costs
From Reuters: “Drugmakers including Pfizer Inc, GlaxoSmithKline PLC, Bristol Myers Squibb, AstraZeneca PLC and Sanofi SA plan to raise prices in the United States on more than 350 unique drugs in early January, according to data analyzed by healthcare research...
